Concepedia

Jeff Zablocki

JZ

32

Publications

1.7K

Citations

27

H-Index

2001

Active since

Affiliations

Carolina Veterinary Specialists(Current)

Gilead Sciences (United States)

Io Therapeutics (United States)

Ligand Pharmaceuticals (United States)

Medical University of South Carolina

Jeff Zablocki is an author at Carolina Veterinary Specialists specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2001–2020

32

Publications

32

A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Suppresses Experimental Arrhythmias

Luiz Belardinelli, Gongxin Liu, Cathy Smith-Maxwell et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 189 citations

Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists

Zhenhai Gao, Zhihe Li, Stephen P. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 120 citations

Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Na <sub>v</sub> 1.7)

James R. Walker, Paul Novick, William H. Parsons et al. · Proceedings of the National Academy of Sciences · 2012 · 99 citations · Full text

Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Lina Yao, Peidong Fan, María Pía Arolfo et al. · Nature Medicine · 2010 · 97 citations · Full text

, , +11

Suppression of Heavy Drinking and Alcohol Seeking by a Selective ALDH‐2 Inhibitor

María Pía Arolfo, David H. Overstreet, Lina Yao et al. · Alcoholism Clinical and Experimental Research · 2009 · 90 citations · Full text

Rows per page

1–5 of 32